Abstract: Modulation of the sialic acid content of cell-surface glycoproteins and glycolipids influences the functional capacity of cells of the immune system. The role of sialidase(s) and the consequent desialylation of cell surface glycoconjugates in the activation of monocytes have not been established. In this study, we show that desialylation of glycoconjugates on the surface of purified monocytes using exogenous neuraminidase (NANase) activated extracellular signal-regulated kinase 1/2 (ERK 1/2), an intermediate in intracellular signaling pathways. Elevated levels of phosphorylated ERK 1/2 were detected in desialylated monocytes after 2 h of NANase treatment, and increased amounts persisted for at least 2 additional hours. Desialylation of cell surface glycoconjugates also led to increased production of interleukin (IL)-6, macrophage inflammatory protein (MIP)-1␣, and MIP-1␤ by NANase-treated monocytes that were maintained in culture. Neither increased levels of phosphorylated ERK 1/2 nor enhanced production of cytokines were detected when NANase was heatinactivated before use, demonstrating the specificity of NANase action. Treatment of monocytes with gram-negative bacterial lipopolysaccharide (LPS) also led to enhanced production of IL-6, MIP-1␣, and MIP-1␤. The amount of each of these cytokines that was produced was markedly increased when monocytes were desialylated with NANase before exposure to LPS. These results suggest that changes in the sialic acid content of surface glycoconjugates influence the activation of monocytes.
INTRODUCTION
Modulation of the sialic acid content of glycoproteins and glycolipids on the surface of diverse types of cells influences cellular activity. Removal of sialic acid from cell surface glycoconjugates affects the interaction of cells with other cells [1] [2] [3] [4] [5] , with soluble regulatory molecules [6 -8] , and with numerous bacteria, protozoa, and viruses [9 -17] . Desialylation of cell surface glycoconjugates has also been shown to have a role in cellular differentiation [18 -20] and transformation [21] [22] [23] .
Terminal sialyl residues are removed from glycoconjugates by neuraminidases (referred to as sialidases in mammalian cells), which comprise a family of enzymes that are widely distributed throughout nature [24] . The significance of sialidase(s) in the normal function of eukaryotic cells has been inferred from the heterogeneous clinical manifestations of individuals with genetic sialidase deficiencies [25] [26] [27] .
The functional capacity of cells of the immune system is influenced by desialylation of cell surface glycoconjugates [1-6, 16, 17, 28 -30] . Treatment of purified T lymphocytes with exogenous, bacterial neuraminidase (NANase) promoted concanavalin A-induced cell proliferation [1] and the production of interleukin (IL)-4 following cell activation [6, 29] . Desialylation of glycoconjugates on the surface of dendritic cells by NANase also resulted in enhanced T cell proliferation [4, 5] and cytotoxic activity [2] in mixed cell assays. We and others [16, 17] have shown that treatment of peripheral blood mononuclear cells (PBMCs) with NANase promoted infection with HIV-1. Desialylation of cell surface glycoconjugates that results from the increased endogenous sialidase activity of activated T cells and monocytes was associated with enhanced cytokine production by lymphocytes [6] and enhanced interaction of monocytes with hyaluronic acid, a component of the extracellular matrix [30] . The mechanism(s) by which desialylation of cell surface glycoconjugates affects the behavior of PBMCs is not understood.
Circulating peripheral blood monocytes are activated by exposure to a variety of extracellular stimuli, enabling them to potentiate diverse immune activities. The surface of monocytes is comprised of sialylated glycoproteins [31] and glycolipids [32] that can be desialylated in vivo by interaction with neuraminidase-expressing microorganisms [15, 33, 34] or by endogenous cellular sialidases [30, [35] [36] [37] . In this manuscript, we demonstrate that desialylation of glycoconjugates on the surface of human monocytes in vitro with NANase (i) stimulates phosphorylation of extracellular signal-regulated kinase 1/2 (ERK 1/2), a critical step in cellular activation through the mitogen-activated protein kinase (MAPK) kinase (MEK)/ERK intracellular signaling pathway; (ii) results in the increased production of specific cytokines, namely interleukin (IL)-6, macrophage-inflammatory protein (MIP)-1␣, and MIP-1␤; and (iii) enhances the cellular response to bacterial lipopolysaccharide (LPS).
MATERIALS AND METHODS

Isolation of PBMCs and purification of monocytes
PBMCs were isolated by leukophoresis of blood from individual HIV-1 and hepatitis B and C seronegative donors followed by centrifugation over FicollPaque Plus (Amersham Pharmacia Biotech, Uppsala, Sweden) gradients using standard procedures. Monocytes were purified from PBMCs by negative selection using StemSep separation columns (Stem Cell Technologies, Vancouver, BC, Canada) as per the manufacturer's suggested protocol. The purity of monocytes exceeded 98% as determined by flow cytometry after staining cells with fluorochrome-labeled antibodies (Ab) to CD3 and CD14, and viability was greater than 97% as determined by trypan blue dye exclusion.
Pretreatment of purified monocytes with NANase
Purified monocytes were suspended at 5 ϫ 10 6 or 1 ϫ 10 7 cells/ml in RPMI-1640 medium (Gibco, Grand Island, NY) containing 10% heat-inactivated (HI) fetal calf serum (Gemini Bioproducts, Calabasas, CA; referred to as complete medium in this manuscript) and were exposed to 100 mU/ml NANase (crystalline, type X, from Clostridium perfringens; Sigma Chemical Co., St. Louis, MO) at 37°C for 15 min-4 h, as noted in each experiment. Where indicated, monocytes were resuspended in phosphate-buffered saline (PBS), pH 7.4, containing 0.5% bovine serum albumin (BSA; Pentex bovine albumin fraction V, Miles Inc., Kankakee, IL) and were treated with NANase as noted above. After treatment with NANase under all conditions, the cells were washed three times with 10 ml PBS at 4°C. NANase was inhibited by being placed in boiling water for 10 min before addition to cells.
Culture conditions for purified monocytes
Mock-and NANase-treated monocytes were maintained at 4 ϫ 10 5 or 2 ϫ 10 6 cells/ml in complete medium at 37°C in a 5% humidified CO 2 incubator. Monocytes (1ϫ10 7 cells/condition) were resuspended in 5 ml (2ϫ10 6 cells/ml) or 25 ml (4ϫ10 5 ) complete medium and were cultured in conical 50 ml polypropylene tubes (Falcon, Becton Dickinson, Franklin Lakes, NJ) at 5 ml cell suspension per tube. In the experiment shown in Figure 3 , mock-and NANase-treated monocytes were prepared as described above and were grown in culture for 24 h in the presence of 0.1 ng/ml LPS (from Escherichia coli; Sigma Chemical Co.).
Analysis of cell surface sialic acid content
Mock-and NANase-treated monocytes (2ϫ10 5 ) were suspended in 0.1 ml PBS, pH 7.4, containing 2% human serum (Gemini Bioproducts, Calabasas, CA) and were incubated with fluorescein isothiocyanate (FITC)-labeled lectin Arachis hypogaea (PNA; EY Laboratories, San Mateo, CA) at 10 g/ml or were left unstained. PNA binds to the galactose moiety that is exposed on cell surface glycoconjugates after removal of terminal sialic acid. Monocytes were incubated with PNA for 45 min at 4°C before unbound lectin was removed by washing the cells at 4°C with 2 ml PBS, pH 7.4, containing 2% human serum. Cells were fixed in 1% paraformaldehyde and analyzed by flow cytometry using a Becton Dickinson FACSCaliber (Mountain View, CA). Data were analyzed using FlowJo data analysis software.
Determination of ERK 1/2 phosphokinase activity
Mock-or NANase-treated monocytes were maintained in culture in complete medium in 50 ml polypropylene tubes. After collection at the indicated times by centrifugation, an equal number of cells from each condition was lysed for 15 min at 4°C in a solution containing 20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerolphosphate, 1 mM sodium orthovanadate, 1 g/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride. After a 5-min centrifugation at 21,000 g in an Eppendorf 5417R microfuge to remove cell debris, the supernatants were collected, and 25 g protein from each cell lysate was separated on a 12% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE), transferred to polyvinylidene fluoride membranes, and probed with rabbit Ab to phosphorylated ERK 1/2 (New England Biolabs, Beverly, MA) or to total ERK 1/2 (Santa Cruz Biotechnology, Santa Cruz, CA) as described elsewhere [38] . The blots were incubated with a 1:1000 dilution of horseradish peroxidase-conjugated antirabbit Ab (Amersham, Arlington Heights, IL), developed using the enhanced chemiluminescence plus kit (Amersham), and were exposed to Kodak M35A-X-OMAT film. To reprobe the same membrane with different Ab, previously bound Ab were stripped in a solution containing 0.1 M glycine, pH 2.9.
Determination of cytokine levels
Enzyme-linked immunosorbent assay (ELISA) were used to determine cytokine levels in the medium of cultured monocytes using kits for IL-6, tumor necrosis factor ␣ (TNF-␣), and IL-10 (R&D Systems, Minneapolis, MN) and IL-1␤, interferon-␥ (IFN-␥), MIP-1␣, MIP-1␤, and regulated on activation, normal T expressed and secreted (RANTES) chemokine (Endogen, Woburn, MA).
RESULTS
Most of the potential sialylation sites of accessible glycoconjugates on the surface of freshly isolated monocytes are sialylated
To determine the relative degree of sialylation of glycoconjugates on the surface of freshly isolated human monocytes, purified monocytes were mock-and NANase-treated and were evaluated by flow cytometry for the relative amount of lectin PNA that specifically bound to the exposed penultimate galactose residue of desialylated cell surface glycoconjugates [28, 35, 39] . FITC-labeled PNA bound to the surface of freshly isolated, mock-treated monocytes, yielding a mean channel fluorescence (MCF) of 57 ( Fig. 1, shaded area) , which was approximately tenfold greater than the fluorescence of unstained, mock-treated cells (Fig. 1 , thin line). After monocytes were treated with 100 mU/ml NANase, there was a greater than 20-fold increase in the amount of PNA that bound to the cell surface (MCF, 1286; Fig. 1, bold line) . Thus, at least 95% of potential sialylation sites on surface glycoconjugates that were accessible to exogenous NANase were sialylated in freshly isolated monocytes.
Desialylation of monocytes activates ERK 1/2
The MAPKs ERK 1/2 are intermediates in the MEK/ERK intracellular signaling pathway, which are phosphorylated in cells that have been activated by a variety of extracellular stimuli (reviewed in refs. [40, 41] ). To determine whether desialylation of cell surface sialoconjugates with exogenous NANase activated monocytes, as evidenced by signaling through the ERK 1/2 pathway, freshly isolated monocytes were treated with NANase and analyzed for an increase in phosphorylation of ERK 1/2. Monocytes that were mock-treated supported a low level of ERK 1/2 phosphorylation (Fig. 2, A  and B) . This level of baseline activity increased minimally in mock-treated monocytes that were maintained in culture over a 4-h period ( Fig. 2A) . In contrast, NANase-treated monocytes expressed increased amounts of phosphorylated ERK 1/2 when analyzed 2 h after desialylation (Fig. 2, A and B) . This difference in amount of phosphorylated ERK 1/2 in NANase-treated cells did not result from increased synthesis of ERK 1/2, as there was no difference in the amount of total ERK 1/2 in mock-and NANase-treated cells (Fig. 2B) . Enhanced phosphorylation of ERK 1/2 in NANase-treated cells continued to be detected when analyzed after 4 h of treatment but at a level that was lower than what occurred after 2 h. Increased phosphorylation of ERK 1/2 was not observed in monocytes that were treated with heat-inactivated (HI) NANase (Fig. 2B) , dismissing the possibility that the observed cellular response was caused by endotoxin or by antigenic stimulation of monocytes by exposure to exogenous NANase.
Desialylation of monocytes leads to increased secretion of cytokines
NANase-treated monocytes that were maintained in culture in complete medium were also evaluated for the production of cytokines. NANase-treated monocytes produced greater amounts of IL-6 within 24 h after NANase treatment than did mock-treated cells from five donors that were evaluated ( Table  1) . Increased amounts of the chemokines MIP-1␣ and MIP-1␤ were also detected in the medium of NANase-treated monocytes in four of five donors (Table 1 ). In contrast, the level of RANTES in medium from cells from each donor was not affected by NANase treatment. Analysis for the cytokines TNF 1 . Treatment of purified monocytes with NANase removes cell surface sialic acid. Monocytes were purified from the peripheral blood of a human donor and were mock-treated and treated with NANase at 100 mU/ml at 37°C for 1 h. Mock-treated (shaded area) and NANase-treated (solid bold line) cells were stained with FITC-labeled PNA, which binds to the penultimate galactose residue of glycoconjugates after removal of terminal sialic acid. Alternatively, mock-treated cells were left unstained (thin solid line). Cells were fixed in 1% paraformaldehyde and were analyzed for the amount of PNA bound to the cell surface by flow cytometry as described in Materials and Methods. Relative amounts of desialylation were determined by comparing the MCF of FITClabeled cells under each condition. These data are from the monocytes of an individual donor and are representative of data using cells from three donors. levels of IL-6, MIP-1␣, and MIP-1␤ were not detected in the medium of cells that were treated with HI NANase (Table 1 , Donors A, C, and E). Similar results were obtained when cells for treatment with NANase were resuspended in PBS, pH 7.4, containing 0.5% BSA, rather than in complete medium (Donors B and E). This confirmed that the effect of NANase was a result of desialylation of cell surface glycoconjugates and not a result of desialylation of exogenous components in the medium. Thus, desialylation of freshly isolated monocytes by exogenous NANase leads to increased production of cytokines in monocytes.
Enhanced production of cytokines by NANasetreated cells occurs independently of cell concentration
To determine whether the enhanced cytokine production of NANase-treated cells resulted from increased homotypic adhesion of desialylated cells, freshly isolated monocytes were treated with 100 mU/ml NANase and maintained in culture at more dilute cell concentrations than were used in the experiments in Table 1 to reduce the amount of cell-to-cell contact. Monocytes from two donors (1ϫ10 7 cells from each), which were treated with NANase at 1 ϫ 10 7 cells/ml in complete medium and subsequently maintained in culture at 2 ϫ 10 6 cells/ml, released 8099 and 9796 picograms of IL-6 into the culture medium ( Table 2) . In contrast to the presentation of data in Table 1 , where cytokine levels are expressed in pg/ml, the data in Table 2 show the total amount of IL-6 that was released into the culture medium. Similar total amounts of IL-6 were released into the medium when the same number of cells from each donor (1ϫ10 7 cells) was treated with NANase at 5 ϫ 10 6 cells/ml (twofold dilution) and subsequently maintained in culture at 4 ϫ 10 5 cells/ml (fivefold dilution; Table 2 ). Thus, the amount of IL-6 that was produced in NANase-treated cells did not appear to depend on the cell concentration during NANase treatment or subsequent cell culture, suggesting that the NANase effect may be a result of its effect on individual cells as opposed to resulting from cell-to-cell adhesion.
Desialylation of monocytes enhances production of cytokines in response to LPS
Monocytes respond to microbial products such as gram-negative bacterial LPS by initiating production of a wide variety of inflammatory mediators. To determine whether the effect of LPS on monocytes was affected by the state of sialylation of cell surface glycoconjugates, the production of IL-6, MIP-1␣, and MIP-1␤ in monocytes was determined after monocytes were first treated with NANase and then exposed to LPS. A low concentration of LPS (0.1 ng/ml) was used to elicit a suboptimal cytokine response. In the absence of exposure to LPS or treatment with NANase, no or minimal cytokine production was observed (Fig. 3 and Table 1 ). In contrast, desialylation of cell surface glycoconjugates by treatment with NANase or exposure of cells to 0.1 ng/ml LPS resulted in production of detectable amounts of IL-6 (NANase, 1.9 ng/ml; LPS, 6.2 ng/ml), MIP-1␣ (NANase, 0.2 ng/ml; LPS, 0.2 ng/ml), and MIP-1␤ (NANase, 1.4 ng/ml; LPS, 0.7 ng/ml). However, when monocytes were pretreated with NANase and subsequently exposed to LPS, a significant increase in inflammatory mediator production occurred with production of 26.9 ng/ml IL-6, 5.0 ng/ml MIP-1␣, and 4.6 ng/ml MIP-1␤. Thus, desialylation of cell surface glycoconjugates promoted a state in monocytes that increased their responsiveness to an exogenous mediator such as LPS.
DISCUSSION
We have shown in this report that desialylation of glycoconjugates on the surface of monocytes leads to increased phosphor- Monocytes (1ϫ10 7 cells) were resuspended in complete medium at a cell concentration of 1 ϫ 10 7 /ml or 5 ϫ 10 6 /ml and were treated with 100 mU/ml NANase. After a 1-h incubation at 37°C and removal of NANase by washing and centrifugation, the cells that were treated with NANase at 1 ϫ 10 7 /ml were resuspended at 2 ϫ 10 6 /ml in complete medium (5 ml total) and grown in one 50 ml conical tube. The cells that were treated with NANase at 5 ϫ 10 6 /ml were resuspended at 4 ϫ 10 5 cells/ml in complete medium (25 ml total), and 5 ml was distributed into each of five 50 ml conical tubes. The total amount of IL-6 released into the medium in each condition was determined 24 h after NANase treatment. Purified monocytes from Donors B and E from the experiments presented in Table 1 were used in Experiments I and II, respectively. Monocytes were purified from PBMCs of five donors and were analyzed separately. Cells were mock-treated or treated with NANase at 100 mU/ml or with 100 mU/ml NANase that had been HI and were grown in complete medium.
a The amount of each cytokine in a sample of culture medium was determined by ELISA 24 h (Donors A, B, D, and E) or 17 h (Donor C) after treatment.
b NANase (HI): NANase was inactivated in boiling water for 10 min prior to exposure to cells. Cells from Donors B and D were not exposed to HI NANase.
c Monocytes were resuspended in PBS containing 0.5% BSA rather than in complete medium for treatment with NANase.
ylation of ERK 1/2 and to enhanced production of specific cytokines. The effects of desialylating cell surface glycoconjugates were demonstrated by maintaining mock-and NANasetreated monocytes in growth conditions that minimized the baseline level of cellular activation. The results of treating monocytes with NANase were specific for desialylation of cell surface glycoconjugates and not simply a result of NANase-induced antigenic stimulation, as enhanced cellular activation did not occur when NANase was heat inactivated before exposure to cells. In addition, similar results were obtained when monocytes were resuspended in PBS, rather than in serum-containing medium, before treatment with NANase, confirming that the NANase effect on monocytes was not a result of desialylation of a component(s) in the medium.
The MEK/ERK MAPK pathway is one of several intracellular signaling pathways (e.g., p38, c-Jun) that is stimulated by cell surface contact with a wide range of stimuli (reviewed in refs. [40 -42] ). In this study, we determined the effect of NANase treatment of monocytes on the MEK-ERK intracellular signaling pathway, but it is possible that other signaling pathways were similarly activated. We observed a complex profile of cytokine expression in desialylated monocytes (increased IL-6, MIP-1␣, MIP-1␤; unaffected TNF-␣, IL-1, IFN-␥, IL-10, RANTES). The enhanced production of IL-6 by NANase-treated monocytes from every donor in our experiments may be the result of activated nuclear factor-B [43] and may reflect the vigorous expression of IL-6 in comparison with other cytokines that occurs in inflammatory states [44, 45] . The qualitative and quantitative differences in cytokine production from all donors in our experiments may partly be explained by the well-recognized genetic polymorphisms that control the production of specific cytokines in different individuals in response to inflammatory stimuli [46 -48] and/or by differences in the baseline state of activation of the purified monocytes from independent donors in separate experiments. Our finding of enhanced cytokine production in desialylated monocytes is consistent with reports from other laboratories that demonstrate increased production of specific cytokines in lymphocytes that were desialylated with exogenous microbial NANases [6, 29] .
There are several possible mechanisms to explain how desialylation of glycoconjugates on the surface of monocytes is involved in intracellular signaling. Modulation of the sialylation status of cell surface receptors and regulatory molecules may modify the ability of these surface-recognition molecules to bind extracellular ligands such as gram-negative bacterial LPS, cytokines, growth factors, and hormones. Alternatively, desialylation of regulatory molecules on the surface of monocytes may lead to receptor activation independently of binding to exogenous ligands by inducing conformational changes in the involved molecules and/or receptor dimerization. In this study, we found that desialylation of glycoconjugates on the surface of monocytes, including possibly the Toll-like receptor 4 complex that recognizes LPS and through which LPS transmits its intracellular signal [49] , enhanced the cellular response to LPS as determined by cytokine production. This finding suggests that desialylation of monocytes affects their functional activity by potentiating the effect of soluble mediators, such as LPS. It is also possible that desialylation of cell surface glycoconjugates increases cell-to-cell interactions as we demonstrated previously in polymorphonuclear leukocytes [28, 50] and as others showed in PBMCs [1, 4] .
Several pathways can be envisioned by which desialylation of cell surface glycoconjugates occurs on monocytes in vivo during their normal immune function. Monocytes express increased endogenous sialidase activity and have hyposialylated cell surface glycoconjugates when they are activated [30] . Monocytes also express increased endogenous sialidase as they differentiate into macrophages or immature dendritic cells (manuscript in preparation). Thus, glycoconjugates on the surface of monocytes can be desialylated by endogenous sialidase(s) after immune activation or by the sialidase(s) on neighboring monocytes, lymphocytes, neutrophils, or endothelial cells, all of which express sialidase activity [3, 6, 30, [35] [36] [37] that can be induced by inflammatory stimuli. Alternatively, interaction with NANase-expressing microorganims such as influenza virus or trypanosomes [15, 34] can potentially lead to desialylation of cell surface glycoconjugates on monocytes.
Activation of monocytes is clearly a multistep process that may include desialylation of cell surface glycoconjugates. It should be noted that sialidases likely work in a microenvironment with sialyltransferases, enzymes that add sialyl residues to glycoconjugates and restore the basal state of cell surface sialylation [51] . Thus, control of cell function may depend on a delicate balance of activity of these enzymes.
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